Clinical Trial Update: Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS) [Phase 3]

View source ↗

Summary

The Phase 3 CATS trial evaluating satavaptan for ascites due to liver cirrhosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Liver Cirrhosis

Drugs mentioned

• Satavaptan (satavaptan)

Snippet

Sponsor: Sanofi | Conditions: Ascites, Liver Cirrhosis | Phase 3 | Status: COMPLETED